However, NEAT1 has been reported as deregulated in neurodegenerative diseases [11] and in the majority of tumors [2] and is known to be a direct target of the transcription factor p53 that, as is common and established knowledge, is defined as the guardian of the genome [3,4,50,51,52]. This evidence concerns the gene TP53 and neurodegenerative disease.